Coya Therapeutics (COYA) Current Taxes (2023 - 2024)
Coya Therapeutics (COYA) posted Current Taxes of $723852.0 for Q1 2024, little changed sequentially from $723852.0 in Q4 2023.
Coya Therapeutics (COYA) Current Taxes (2023 - 2024) Analysis & Trends
Coya Therapeutics has reported Current Taxes for 2 years, with the latest figure at $723852.0 in Q1 2024.
- Quarterly Current Taxes changed N/A year-over-year to $723852.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $723852.0 (changed N/A YoY) and the FY2023 annual result came in at $723852.0, changed N/A from the prior year.
- Current Taxes was little changed at $723852.0 in Q1 2024 per COYA's latest filing, from $723852.0 in the prior quarter.
- Over five years, Current Taxes peaked at $723852.0 in Q4 2023 and troughed at $723852.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | - |
| 10 | Coya Therapeutics | 114.94 Mn | 71.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 723,852.00 |
| Dec 31, 2023 | 723,852.00 |